+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Immunology and Emerging Infectious Diseases · Registering as Listener

ICI-EID
📅 8 – 9 Apr 2027 📍 Melbourne, Australia 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Immunology and Emerging Infectious Diseases
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9 SDG 10

This track focuses on the latest innovations in vaccine research, including novel adjuvants and delivery systems. Participants will discuss the challenges and successes in developing vaccines for emerging infectious diseases.

This session will explore the complex interactions between pathogens and host immune systems. Researchers will present findings on how these interactions influence disease progression and immune responses.

This track will examine the epidemiological trends of newly emerging infectious diseases globally. Discussions will include risk factors, transmission dynamics, and the role of environmental changes.

This session will highlight the role of clinical immunology in diagnosing and managing infectious diseases. Experts will share case studies and best practices for improving patient outcomes.

This track will focus on the methodologies and technologies used in outbreak surveillance. Participants will discuss effective response strategies to mitigate the impact of infectious disease outbreaks.

This session will delve into the genetic factors that influence immune responses and susceptibility to infectious diseases. Research findings will be presented on the role of genetic polymorphisms in immunological outcomes.

This track will explore novel strategies for preventing infectious diseases, including public health initiatives and community engagement. Participants will discuss the effectiveness of these approaches in various populations.

This session will highlight the importance of animal models in understanding infectious diseases and testing vaccines. Researchers will present their findings on how these models contribute to translational research.

This track will showcase cutting-edge technologies that are transforming the field of immunology. Discussions will include advancements in diagnostic tools, therapeutic interventions, and personalized medicine.

This session will address the global implications of infectious diseases and the importance of international collaboration in research and public health. Participants will share insights on policy-making and resource allocation.

This track will explore the ethical challenges associated with vaccine development and deployment. Discussions will focus on informed consent, equity in access, and the implications of vaccine hesitancy.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED